Merus kündigt Präsentation der klinischen Daten der Phase I für MCLA-158 auf dem „2021 Gastrointestinal Cancers Symposium“ der American Society of Clinical Oncology (ASCO) an

Ads

You May Also Like

Collegium Announces Scientific Presentation at American Academy of Pain Medicine 2017 Meeting

CANTON, Mass., March 16, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced ...

Protech Home Medical Releases Third Quarter Financial Results

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES ...